FRACTIONAL CMO & MEDICAL LEADERSHIP

Leadership should govern
the programme before drift
becomes structure.

Senior medical leadership for development strategy, governance,
capital-facing decisions and high-stakes programme judgement.

THE LEADERSHIP QUESTION

Where does senior judgement
need to become accountable?

Decision ownership

Clear accountability for critical
development decisions.

Medical judgement

Independent, evidence-based
clinical and scientific judgement.

Board-level alignment

A coherent position for boards,
investors and strategic partners.

OUR LEADERSHIP PATHWAY

1 Diagnose

Assess leadership gaps,
decision rights and
programme risks.

Prioritise

Focus on the decisions
that will most influence
value.

Align

Build consensus across
clinical, development
and commercial.

Govern

Establish structures
and cadence for
accountable oversight.

Represent

Support board, investor
and partner engagement
with a credible voice.

Steer

Provide ongoing senior
advice as the programme
evolves.

WHAT WE OFTEN CHANGE FIRST

Unclear accountability

Decision ownership is diffuse,
slowing progress and increasing risk.

Fragmented decisions

Clinical, development and commercial
decisions are misaligned.

Delayed escalation

Critical issues are not raised
or resolved early enough.

Weak capital narrative

The clinical story is not investment-ready
or lacks credibility.

Preventable CRO drift

Key decisions are delegated without
sufficient strategic oversight.

NEXT DISCUSSION

Leadership should governthe programme before driftbecomes structure.

Where does senior judgementneed to become accountable?